Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

1.

The hormonal response of estrogen receptor beta is decreased by the phosphatidylinositol 3-kinase/Akt pathway via a phosphorylation-dependent release of CREB-binding protein.

Sanchez M, Sauvé K, Picard N, Tremblay A.

J Biol Chem. 2007 Feb 16;282(7):4830-40. Epub 2006 Dec 12.

PMID:
17166829
[PubMed - indexed for MEDLINE]
Free Article
2.

Coordinate regulation of estrogen receptor β degradation by Mdm2 and CREB-binding protein in response to growth signals.

Sanchez M, Picard N, Sauvé K, Tremblay A.

Oncogene. 2013 Jan 3;32(1):117-26. doi: 10.1038/onc.2012.19. Epub 2012 Feb 20.

PMID:
22349818
[PubMed - indexed for MEDLINE]
3.

Estrogen-related receptor alpha1 transcriptional activities are regulated in part via the ErbB2/HER2 signaling pathway.

Ariazi EA, Kraus RJ, Farrell ML, Jordan VC, Mertz JE.

Mol Cancer Res. 2007 Jan;5(1):71-85.

PMID:
17259347
[PubMed - indexed for MEDLINE]
Free Article
4.

Contribution of steroid receptor coactivator-1 and CREB binding protein in ligand-independent activity of estrogen receptor beta.

Tremblay A, Giguère V.

J Steroid Biochem Mol Biol. 2001 Apr;77(1):19-27.

PMID:
11358671
[PubMed - indexed for MEDLINE]
5.

The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT.

Wang X, Yang Z, Zhang H, Ding L, Li X, Zhu C, Zheng Y, Ye Q.

Biochim Biophys Acta. 2008 Jun;1783(6):1220-8. doi: 10.1016/j.bbamcr.2008.01.026. Epub 2008 Feb 12.

PMID:
18302941
[PubMed - indexed for MEDLINE]
Free Article
6.

Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.

Sauvé K, Lepage J, Sanchez M, Heveker N, Tremblay A.

Cancer Res. 2009 Jul 15;69(14):5793-800. doi: 10.1158/0008-5472.CAN-08-4924. Epub 2009 Jul 7.

PMID:
19584281
[PubMed - indexed for MEDLINE]
Free Article
7.

Activation of ERbeta increases levels of phosphorylated nNOS and NO production through a Src/PI3K/Akt-dependent pathway in hypothalamic neurons.

Gingerich S, Krukoff TL.

Neuropharmacology. 2008 Oct;55(5):878-85. doi: 10.1016/j.neuropharm.2008.06.058. Epub 2008 Jul 4.

PMID:
18652836
[PubMed - indexed for MEDLINE]
8.

Estrogen receptor beta mediates increased activation of PI3K/Akt signaling and improved myocardial function in female hearts following acute ischemia.

Wang M, Wang Y, Weil B, Abarbanell A, Herrmann J, Tan J, Kelly M, Meldrum DR.

Am J Physiol Regul Integr Comp Physiol. 2009 Apr;296(4):R972-8. doi: 10.1152/ajpregu.00045.2009. Epub 2009 Feb 11.

PMID:
19211725
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Selective hormone-dependent repression of estrogen receptor beta by a p38-activated ErbB2/ErbB3 pathway.

St-Laurent V, Sanchez M, Charbonneau C, Tremblay A.

J Steroid Biochem Mol Biol. 2005 Feb;94(1-3):23-37. Epub 2005 Mar 16.

PMID:
15862947
[PubMed - indexed for MEDLINE]
10.

Estrogen facilitates both phosphatidylinositol 3-kinase/Akt and ERK1/2 mitogen-activated protein kinase membrane signaling required for long-term neuropeptide Y transcriptional regulation in clonal, immortalized neurons.

Titolo D, Mayer CM, Dhillon SS, Cai F, Belsham DD.

J Neurosci. 2008 Jun 18;28(25):6473-82. doi: 10.1523/JNEUROSCI.0514-08.2008.

PMID:
18562618
[PubMed - indexed for MEDLINE]
Free Article
11.
12.

CREB is a regulatory target for the protein kinase Akt/PKB.

Du K, Montminy M.

J Biol Chem. 1998 Dec 4;273(49):32377-9.

PMID:
9829964
[PubMed - indexed for MEDLINE]
Free Article
13.

17 beta-estradiol activates PI3K/Akt signaling pathway by estrogen receptor (ER)-dependent and ER-independent mechanisms in endometrial cancer cells.

Guo RX, Wei LH, Tu Z, Sun PM, Wang JL, Zhao D, Li XP, Tang JM.

J Steroid Biochem Mol Biol. 2006 Apr;99(1):9-18. Epub 2006 Mar 29.

PMID:
16567092
[PubMed - indexed for MEDLINE]
14.

Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma.

Tokunaga E, Oki E, Kimura Y, Yamanaka T, Egashira A, Nishida K, Koga T, Morita M, Kakeji Y, Maehara Y.

Breast Cancer Res Treat. 2007 Mar;101(3):249-57. Epub 2006 Sep 28.

PMID:
17006756
[PubMed - indexed for MEDLINE]
15.

Increased pancreatic beta-cell proliferation mediated by CREB binding protein gene activation.

Hussain MA, Porras DL, Rowe MH, West JR, Song WJ, Schreiber WE, Wondisford FE.

Mol Cell Biol. 2006 Oct;26(20):7747-59. Epub 2006 Aug 14.

PMID:
16908541
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

AKT regulation of estrogen receptor beta transcriptional activity in breast cancer.

Duong BN, Elliott S, Frigo DE, Melnik LI, Vanhoy L, Tomchuck S, Lebeau HP, David O, Beckman BS, Alam J, Bratton MR, McLachlan JA, Burow ME.

Cancer Res. 2006 Sep 1;66(17):8373-81.

PMID:
16951146
[PubMed - indexed for MEDLINE]
Free Article
17.

Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cells.

Sengupta S, Schiff R, Katzenellenbogen BS.

Breast Cancer Res Treat. 2009 Sep;117(2):243-51. doi: 10.1007/s10549-008-0186-z. Epub 2008 Sep 19.

PMID:
18807177
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Interleukin (IL) 1beta induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT/IkappaB kinase alpha pathway targeting activator protein-1.

Cahill CM, Rogers JT.

J Biol Chem. 2008 Sep 19;283(38):25900-12. doi: 10.1074/jbc.M707692200. Epub 2008 May 30.

PMID:
18515365
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Protein kinase B activity is sufficient to mimic the effect of insulin on glucagon gene transcription.

Schinner S, Barthel A, Dellas C, Grzeskowiak R, Sharma SK, Oetjen E, Blume R, Knepel W.

J Biol Chem. 2005 Feb 25;280(8):7369-76. Epub 2004 Dec 7.

PMID:
15590659
[PubMed - indexed for MEDLINE]
Free Article
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk